FDA Adverse Event Injury Summary report: N

ENDOTAK RELIANCE

MDR report key: 3213668 · Received July 9, 2013

Report

Report Number
2124215-2013-10225
Event Type
Injury
Date Received
July 9, 2013
Date of Event
November 17, 2012
Report Date
April 17, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
PMA / PMN Number
P910073
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
PATIENT FAMILY MEMBER OR FRIEND

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS PRODUCT WAS INVOLVED IN INFECTION. THE LEAD WAS DETACHED AND HAD BACTERIA ON IT. THE FIELD REPRESENTATIVE WAS NOT ABLE TO IDENTIFY WHAT HAD SPECIFICALLY DETACHED AMONG THE LEADS AFTER ATTEMPTS WERE MADE TO OBTAIN ADDITIONAL INFORMATION. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED. ALL AVAILABLE INFORMATION INDICATES THAT THE PRODUCT REMAINS IN SERVICE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
312062 ENDOTAK RELIANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0158

Patients

Seq Age Sex Outcome Treatment
1 81 YR Hospitalization| L| R 4470| E110| 4312| 1861| 0158| 0041